Extra anti-clotting medicine for stroke after initial treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether adding a medicine called eptifibatide, which helps prevent blood clots, can improve recovery for people who had a stroke and did not get better enough after standard clot-busting treatment. It may help reduce disability if given soon after the initial treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- Had an ischemic stroke (blocked blood vessel in the brain) and are arriving at the hospital 4.5 to 24 hours after symptoms started
- Have at least a moderate level of stroke symptoms (a score of 4 or higher on a stroke scale)
- Have already received standard clot-busting medicine (thrombolysis) but did not improve, got worse, or had fluctuating symptoms afterwards
- Be able to receive the study drug within 1 hour after finishing the clot-busting medicine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
This trial tests whether adding a medicine called tirofiban (which helps prevent blood clots) after standard stroke treatment can improve recovery in people who had a stroke due to a blocked large artery in the brain. It is for people who already received a clot-busting drug and a mechanical clot removal procedure, and who have not fully recovered.
This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.
This trial tests whether giving a medication called tirofiban directly into the artery (intra-arterially) after a successful clot removal can improve recovery after a stroke. Tirofiban helps prevent new clots from forming, which may reduce the chance of another stroke.
This trial tests whether adding a second medicine (tirofiban) to standard clot-busting treatment can help people who are not improving after the first hour. It is for people with a moderate to severe stroke who are not candidates for a clot-removal procedure.
This study tests whether giving the blood-thinning drug tirofiban for a shorter or longer time after standard clot-busting treatment improves recovery from a stroke. It aims to find the best duration to prevent further damage while avoiding side effects.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.